345 related articles for article (PubMed ID: 24363993)
21. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
[TBL] [Abstract][Full Text] [Related]
22. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy.
Deliyanti D; Alrashdi SF; Tan SM; Meyer C; Ward KW; de Haan JB; Wilkinson-Berka JL
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):815-825. PubMed ID: 29411009
[TBL] [Abstract][Full Text] [Related]
24. The involvement of Nrf2 in the protective effects of diallyl disulfide on carbon tetrachloride-induced hepatic oxidative damage and inflammatory response in rats.
Lee IC; Kim SH; Baek HS; Moon C; Kang SS; Kim SH; Kim YB; Shin IS; Kim JC
Food Chem Toxicol; 2014 Jan; 63():174-85. PubMed ID: 24246655
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
[TBL] [Abstract][Full Text] [Related]
26. The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells.
Ding Y; Stidham RD; Bumeister R; Trevino I; Winters A; Sprouse M; Ding M; Ferguson DA; Meyer CJ; Wigley WC; Ma R
Kidney Int; 2013 May; 83(5):845-54. PubMed ID: 23235569
[TBL] [Abstract][Full Text] [Related]
27. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
28. A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy.
Deliyanti D; Lee JY; Petratos S; Meyer CJ; Ward KW; Wilkinson-Berka JL; de Haan JB
Clin Sci (Lond); 2016 Aug; 130(15):1375-87. PubMed ID: 27005782
[TBL] [Abstract][Full Text] [Related]
29. Bardoxolone treatment alleviates lipopolysaccharide (LPS)-induced acute lung injury through suppressing inflammation and oxidative stress regulated by Nrf2 signaling.
Pei X; Zhang XJ; Chen HM
Biochem Biophys Res Commun; 2019 Aug; 516(1):270-277. PubMed ID: 31248593
[TBL] [Abstract][Full Text] [Related]
30. Phosphate Binder, Ferric Citrate, Attenuates Anemia, Renal Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in 5/6 Nephrectomized CKD Rats.
Jing W; Nunes ACF; Farzaneh T; Khazaeli M; Lau WL; Vaziri ND
J Pharmacol Exp Ther; 2018 Oct; 367(1):129-137. PubMed ID: 30093458
[TBL] [Abstract][Full Text] [Related]
31. Pterostilbene protects against uraemia serum-induced endothelial cell damage via activation of Keap1/Nrf2/HO-1 signaling.
Chen ZW; Miu HF; Wang HP; Wu ZN; Wang WJ; Ling YJ; Xu XH; Sun HJ; Jiang X
Int Urol Nephrol; 2018 Mar; 50(3):559-570. PubMed ID: 29094331
[TBL] [Abstract][Full Text] [Related]
32. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
[TBL] [Abstract][Full Text] [Related]
33. ApoA-1 mimetic peptide reverses uremia-induced upregulation of pro-atherogenic pathways in the aorta.
Vaziri ND; Bai Y; Yuan J; Said HL; Sigala W; Ni Z
Am J Nephrol; 2010; 32(3):201-211. PubMed ID: 20639628
[TBL] [Abstract][Full Text] [Related]
34. CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes.
Reisman SA; Buckley DB; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2009 Apr; 236(1):109-14. PubMed ID: 19371629
[TBL] [Abstract][Full Text] [Related]
35. Effect of redox modulating NRF2 activators on chronic kidney disease.
Choi BH; Kang KS; Kwak MK
Molecules; 2014 Aug; 19(8):12727-59. PubMed ID: 25140450
[TBL] [Abstract][Full Text] [Related]
36. RTA-dh404 decreased oxidative stress in mice ischemic limbs and augmented efficacy of therapeutic angiogenesis by intramuscular injection of adipose-derived regenerative cells in the limbs.
Ishizaki Y; Sasaki KI; Yoshikawa T; Nakayoshi T; Sasaki M; Ohtsuka M; Hatada-Katakabe S; Takata Y; Fukumoto Y
Eur J Pharmacol; 2023 Jan; 938():175422. PubMed ID: 36442622
[TBL] [Abstract][Full Text] [Related]
37. Betulinic acid attenuates lipopolysaccharide-induced vascular hyporeactivity in the rat aorta by modulating Nrf2 antioxidative function.
Bai YY; Yan D; Zhou HY; Li WX; Lou YY; Zhou XR; Qian LB; Xiao C
Inflammopharmacology; 2020 Feb; 28(1):165-174. PubMed ID: 31352642
[TBL] [Abstract][Full Text] [Related]
38. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
39. Zedoarondiol Attenuates Endothelial Cells Injury Induced by Oxidized Low-Density Lipoprotein via Nrf2 Activation.
Mao H; Tao T; Wang X; Liu M; Song D; Liu X; Shi D
Cell Physiol Biochem; 2018; 48(4):1468-1479. PubMed ID: 30064139
[TBL] [Abstract][Full Text] [Related]
40. Salvianolic Acid A Protects the Kidney against Oxidative Stress by Activating the Akt/GSK-3
Zhang HF; Wang JH; Wang YL; Gao C; Gu YT; Huang J; Wang JH; Zhang Z
Oxid Med Cell Longev; 2019; 2019():2853534. PubMed ID: 31011401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
